Literature DB >> 9105759

Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.

D Weissman1, A S Fauci.   

Abstract

The role of dendritic cells (DC) in the pathogenesis of human immunodeficiency virus (HIV) disease has been a subject of considerable interest for several years. Initial studies focused on the infection, dysfunction, and depletion of DC in HIV-infected individuals. More recent studies have begun to identify the functional role of DC in the initiation and propagation of viral replication in T cells in HIV-infected individuals. This review discusses recent data regarding the role of DC in HIV disease with the aim of delineating basic immunopathogenic principles of infection and the development of therapeutic strategies.

Entities:  

Mesh：

Year:  1997        PMID： 9105759      PMCID： PMC172924          DOI： 10.1128/CMR.10.2.358

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN： 0893-8512            Impact factor:   26.132


  155 in total

1.  A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily.

Authors:  L J Zhou; R Schwarting; H M Smith; T F Tedder
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

Review 2.  The phenotype of murine Langerhans cells from skin to lymph node.

Authors:  G Kraal; E van Wilsem; J Brevé
Journal:  In Vivo       Date:  1993 May-Jun       Impact factor: 2.155

Review 3.  Dendritic cells "in vivo": migration and antigen handling.

Authors:  G G MacPherson; L Liu
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

4.  Serum-free differentiation of rat and human dendritic cells, accompanied by acquisition of the nuclear lamins A/C as differentiation markers.

Authors:  R K Gieseler; H Xu; R Schlemminger; J H Peters
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

5.  Coexpression of NF-kappa B/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia.

Authors:  A Granelli-Piperno; M Pope; K Inaba; R M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

6.  Human dendritic Langerhans cells generated in vitro from CD34+ progenitors can prime naive CD4+ T cells and process soluble antigen.

Authors:  C Caux; C Massacrier; C Dezutter-Dambuyant; B Vanbervliet; C Jacquet; D Schmitt; J Banchereau
Journal:  J Immunol       Date:  1995-12-01       Impact factor: 5.422

7.  Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells.

Authors:  P U Cameron; P S Freudenthal; J M Barker; S Gezelter; K Inaba; R M Steinman
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

8.  Signals required for differentiating dendritic cells from human monocytes in vitro.

Authors:  J H Peters; H Xu; J Ruppert; D Ostermeier; D Friedrichs; R K Gieseler
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

Review 9.  Langerhans cells and HIV infection.

Authors:  G Zambruno; A Giannetti; U Bertazzoni; G Girolomoni
Journal:  Immunol Today       Date:  1995-11

10.  In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

Authors:  T W Chun; D Finzi; J Margolick; K Chadwick; D Schwartz; R F Siliciano
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440
View more
  14 in total

Review 1.  Dendritic cells: a link between innate and adaptive immunity.

Authors:  K Palucka; J Banchereau
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

2.  The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.

Authors:  Z Nie; D Bergeron; R A Subbramanian; X J Yao; F Checroune; N Rougeau; E A Cohen
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures.

Authors:  H Asada; V Klaus-Kovtun; H Golding; S I Katz; A Blauvelt
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice.

Authors:  C Masurier; B Salomon; N Guettari; C Pioche; F Lachapelle; M Guigon; D Klatzmann
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  HIV-1 infection of placental cord blood monocyte-derived dendritic cells.

Authors:  R M Folcik; J D Merrill; Y Li; C J Guo; S D Douglas; S E Starr; W Z Ho
Journal:  J Hematother Stem Cell Res       Date:  2001-10

6.  Randomized, double-blind, placebo-controlled trial of the immune modulator WF10 in patients with advanced AIDS.

Authors:  S P Raffanti; W Schaffner; C F Federspiel; R B Blackwell; O A Ching; F W Kühne
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

7.  The AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with accumulation of immature CD11bHi dendritic cells.

Authors:  Johanne Poudrier; Xiaoduan Weng; Denis G Kay; Zaher Hanna; Paul Jolicoeur
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  Probing local innate immune responses after mucosal immunisation.

Authors:  Lindsay J Hall; Simon Clare; Gordon Dougan
Journal:  J Immune Based Ther Vaccines       Date:  2010-09-13

9.  Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.

Authors:  M Moriuchi; H Moriuchi; W Turner; A S Fauci
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

10.  Dendritic cell-mediated viral transfer to T cells is required for human immunodeficiency virus type 1 persistence in the face of rapid cell turnover.

Authors:  Suryaram Gummuluru; Vineet N KewalRamani; Michael Emerman
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.